AIM ImmunoTech Inc (AIM)

2.070
+0.040(+1.97%)
After Hours
2.040
-0.030(-1.449%)
- Real-time Data
  • Volume:
    189,263
  • Bid/Ask:
    2.050/2.070
  • Day's Range:
    2.020 - 2.090

AIM Overview

Prev. Close
2.03
Day's Range
2.02-2.09
Revenue
150K
Open
2.02
52 wk Range
1.6-3.11
EPS
-0.37
Volume
189,263
Market Cap
99.01M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
545,267
P/E Ratio
-
Beta
-0.83
1-Year Change
-29.35%
Shares Outstanding
47,832,997
Next Earnings Date
Aug 16, 2021
What is your sentiment on AIM ImmunoTech Inc?
or
Market is currently closed. Voting is open during market hours.

AIM ImmunoTech Inc News

  • Hemispherx Biopharma misses by $0.01
    • BySeeking Alpha-

    Hemispherx Biopharma (NYSEMKT:HEB): Q3 GAAP EPS of -$0.07 misses by $0.01. Cash, cash equivalents and marketable securities of $4.08M Press Release Now read: International Stem...

  • Hemispherx Biopharma reports Q3 results
    • BySeeking Alpha-

    Hemispherx Biopharma (NYSEMKT:HEB): Q3 net loss of $1.3MCash and cash equivalents of $2.3MPress ReleaseNow read: Milestone Scientific reports Q3 resultsOriginal article

AIM ImmunoTech Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyBuySellStrong Sell
Technical IndicatorsSellSellStrong BuyBuyStrong Sell
SummaryNeutralNeutralStrong BuyNeutralStrong Sell

AIM ImmunoTech Inc Company Profile

AIM ImmunoTech Inc Company Profile

Employees
22

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viruses, and immune-deficiency disorders in the United States. The company’s products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, and HIV. The company also provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with UMN Pharma Inc.; Japanese National Institute of Infectious Diseases; and Shionogi & Co., Ltd.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell’Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1990 and is headquartered in Ocala, Florida.

Read More
  • good
    0
    • FDA'd
      0
      • In 5k shares 1.85 lets see
        0
        • now you profit 2250$ already just 1 month
          0
      • now that I'm in, this will fly like a rocket
        0
        • Got in at 2.99. This stock bores me, almost 2 months with no positive movement.
          2
          • Well, finally something's cooking up.
            0
          • hope you sold today
            0
          • Hope u still holding
            0
        • still so quiet
          0
          • I know recruitment is planned to start tomorrow. But please wait another day. This cannot jump before I hop in. Please TT
            0
            • Please wait until Tuesday
              0
            • Okay let's go
              0
          • buy and hold
            1
            • what happened to this company? drop so much
              0
              • Has a long and colorful history of claiming to be a cure for what ever disease du jour is out there.
                1
                • How high today. Been waiting nine months to get my money back. ??
                  0
                  • lol. congrats!!!
                    0
                • buy and hold good for at least 3 a share
                  0
                  • it never reach this low befor it is a risk
                    0
                    • Any opinion?
                      0
                      • should I invest NOW is the question
                        0
                        • Never invest right after a reverse split
                          0
                      • should i invest now?
                        0
                        • should i invest now?
                          0
                          • should i invest now?
                            0
                            • Hmm? What's the future outlook? Worth the investment?
                              0
                              • this company is going to fly up very soon
                                0
                                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.